User:Mr. Ibrahem/Voxelotor

Voxelotor, sold under the brand name Oxbryta, is a medication used to treat sickle cell disease. Evidence shows that it improves hemoglobin levels; however, overall benefits are unclear as of 2021. It is taken by mouth.

Common side effects include headache, abdominal pain, rash, fever, and tiredness. Severe side effects may include allergic reactions. Use in pregnancy is of unclear safety. It is believed to work by improving the ability of abnormal hemoglobin to carry oxygen.

Voxelotor was approved for medical use in the United States in 2019. In Europe it was granted orphan designation in 2016. In the United States it costs about 10,100 USD per month as of 2021.